DFB Pharmaceuticals
Practical innovations for life
banner-leaves.jpg

Partnering

Let's work together.

 

Long history of partnering success.


DFB has a long history of successfully partnering to develop and commercialize innovative technologies across a broad range of product categories and therapeutic areas.  We have operated as both seller or buyer, licensor or licensee, and believe in establishing mutually beneficial relationships that are designed for long-term success.

Available for license or sale

NANOLOGY LLC – NANOPARTICLE PLATFORM

Our NanoPac® Nanoparticle Paclitaxel and NanoDoce® Nanoparticle Docetaxel drug platform is in phase 2 clinical development across multiple indications in oncology, dermatology, and woman’s health. We have built an extensive IP portfolio around this platform and are actively identifying new ways to extend and broaden our IP.

We will communicate clinical findings as data become available in late 2017. Given the breadth of clinical indications afforded by this platform, we intend to identify the right pharmaceutical partner(s) to progress the platform-enabled investigational drugs through pivotal trials, regulatory approval, and to patients who need them.
Learn more about NanOlogy >

DOCETAXEL INJECTION USP (GENERIC EQUIVALENT TO TAXOTERE®)

Our FDA-approved docetaxel injection is available for distribution rights outside the USA. A generic to Taxotere®, our docetaxel injection is available in 20mg/mL, 80mg/4mL, and 200mg/10mL single use vials. Our API is supplied by the only producer in the world that does not rely on problematic 10-DAB as starting material for docetaxel API. Instead, the API used in our docetaxel injection is synthesized from a plant cell fermentation-derived starting material controlled start to finish in GMP facilities. 10-DAB, on the other hand, requires huge quantities of toxic solvents for extraction from non-GMP yew tree plantations, which are subject to weather and harvesting issues, most recently reported in 2015.

INFECTION CONTROL PRODUCTS

Our infection control products have been commercialized in the USA and are available for license in certain geographies around the world. The products include:

  • Aldahol® a high-level disinfectant

  • Surgicept® a waterless surgical hand scrub

  • Triseptin® a water-aided surgical hand scrub

 
 
 

Contact Us

Name *
Name
Please begin with country code if outside the USA or Canada